Bukwang Pharm (003000) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.018x

Based on the latest financial reports, Bukwang Pharm (003000) has a cash flow conversion efficiency ratio of -0.018x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-6.24 Billion ≈ $-4.23 Million USD) by net assets (₩340.83 Billion ≈ $230.98 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Bukwang Pharm liquidity coverage in days to measure how many days the company can operate on defensive assets alone.

Bukwang Pharm - Cash Flow Conversion Efficiency Trend (2007–2024)

This chart illustrates how Bukwang Pharm's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Bukwang Pharm Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Bukwang Pharm ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Huizhong Instrumentation Co Ltd SHE:300371	0.054x
Polaris Media OL:POL	0.072x
Drugs Made In America Acquisition Corp. Units NASDAQ:DMAAU	-0.001x
Nanjing OLO Home Furnishing SHG:603326	0.053x
D. Boral Acquisition I Corp. Class A Ordinary Shares NASDAQ:DBCA	-0.001x
Spirox Corp TW:3055	-0.005x
Fusion Micro Finance Limited NSE:FUSION	0.221x
Jiangsu Holly Corp SHG:600128	0.038x

Annual Cash Flow Conversion Efficiency for Bukwang Pharm (2007–2024)

The table below shows the annual cash flow conversion efficiency of Bukwang Pharm from 2007 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Bukwang Pharm.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩244.15 Billion ≈ $165.45 Million	₩34.36 Billion ≈ $23.29 Million	0.141x	+452.19%
2023-12-31	₩234.26 Billion ≈ $158.76 Million	₩-9.36 Billion ≈ $-6.34 Million	-0.040x	-165.99%
2022-12-31	₩271.85 Billion ≈ $184.23 Million	₩16.46 Billion ≈ $11.16 Million	0.061x	-36.06%
2021-12-31	₩280.06 Billion ≈ $189.79 Million	₩26.52 Billion ≈ $17.98 Million	0.095x	+3451.72%
2020-12-31	₩271.19 Billion ≈ $183.78 Million	₩723.17 Million ≈ $490.08K	0.003x	+103.72%
2019-12-31	₩326.49 Billion ≈ $221.25 Million	₩-23.41 Billion ≈ $-15.86 Million	-0.072x	-534.85%
2018-12-31	₩413.44 Billion ≈ $280.18 Million	₩6.82 Billion ≈ $4.62 Million	0.016x	-59.31%
2017-12-31	₩211.30 Billion ≈ $143.20 Million	₩8.56 Billion ≈ $5.80 Million	0.041x	+212.04%
2016-12-31	₩214.63 Billion ≈ $145.45 Million	₩-7.76 Billion ≈ $-5.26 Million	-0.036x	-179.08%
2015-12-31	₩225.15 Billion ≈ $152.58 Million	₩10.30 Billion ≈ $6.98 Million	0.046x	-65.53%
2014-12-31	₩210.00 Billion ≈ $142.31 Million	₩27.86 Billion ≈ $18.88 Million	0.133x	-26.94%
2013-12-31	₩201.07 Billion ≈ $136.26 Million	₩36.52 Billion ≈ $24.75 Million	0.182x	+11.16%
2007-12-31	₩170.63 Billion ≈ $115.63 Million	₩27.87 Billion ≈ $18.89 Million	0.163x	--

About Bukwang Pharm

KO:003000 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$308.58 Million

₩455.34 Billion KRW

Market Cap Rank

#14772 Global

#496 in Korea

Share Price

₩4615.00

Change (1 day)

-3.35%

52-Week Range

₩3225.00 - ₩9600.00

All Time High

₩36947.85